Key Information
Source
summary/abstract
When my friend Margaret finally got her diagnosis after four years of progressive numbness, weakness, and what her doctors called “idiopathic neuropathy,” we both sat in stunned silence. Amyloid neuropathy — specifically a type called ATTR amyloidosis — wasn't even on our radar. Neither of us had heard of it. And yet, once the diagnosis landed, it changed everything: there were treatments. Real, approved, science-backed treatments that could slow the disease in its tracks.